Cargando...
SAT-308 Obsessive and Compulsive Behavioral Change during Combination Treatment of Aromatase Inhibitor and Recombinant Human Growth Hormone in Early Puberty Patient: A Case Report
Aromatase inhibitor (AI), mostly combined with recombinant human growth hormone (rhGH), has been proposed as a effective treatment to improve the final adult height in short pubertal boys by delaying growth plate closure. However, safety concerns also remain, because of limited safety profile of AI...
Gardado en:
| Publicado en: | J Endocr Soc |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Endocrine Society
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552207/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-308 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|